Kyverna Therapeutics Stock (NASDAQ: KYTX) stock price, news, charts, stock research, profile.
Open | $7.98 |
Close | $8.09 |
Volume / Avg. | 421.89K / 648.60K |
Day Range | $7.80 - $8.78 |
52 Wk Range | 6.30 - 35.06 |
Market Cap | $349.06M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 12.31% |
Days to Cover | 7.76 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kyverna Therapeutics (NASDAQ:KYTX) through any online brokerage.
Other companies in Kyverna Therapeutics’s space includes: Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Inozyme Pharma (NASDAQ:INZY), PepGen (NASDAQ:PEPG) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Kyverna Therapeutics has a consensus price target of $26.67.
The stock price for Kyverna Therapeutics (NASDAQ: KYTX) is $8.09 last updated August 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Kyverna Therapeutics.
Kyverna Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Kyverna Therapeutics.
Kyverna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.